Melissa Nott DavisPartnerMcDermott Will & Schulte LLPWebsitewww.mwe.comBlogwww.mwe.com/insightsConnectEmailTwitterLinkedIn617-535-4189 Professional Biography Melissa Nott Davis is a partner in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Boston office. More Legal and Business Bylines From Melissa Nott Davis Concerted Actions with Sister Company in Finland Result in Delaware Jurisdiction - (Posted On Monday, August 29, 2016) Rosebud LMS Inc. v. Adobe Systems Inc.: Pre-Issuance Damages Possible Only If You “Know” About the Published Application - (Posted On Wednesday, March 30, 2016) Attorneys’ Fee Award Cannot Be Enhanced to Deter Misconduct - (Posted On Thursday, February 25, 2016) There Is More than One Way to Slice the Apportionment Analysis re: Patent litigation - (Posted On Thursday, January 28, 2016) Apple Secures Its Permanent Injunction in Apple v. Samsung Electronics - (Posted On Monday, November 02, 2015) A Primer on Patent Damages: Carnegie Mellon University v. Marvell Technology Group, Ltd., et al. - (Posted On Wednesday, September 30, 2015) A Joint Author Does Not Own Derived Material - (Posted On Thursday, August 27, 2015) Arborjet, Inc. v. Rainbow Treecare Scientific Advancements, Inc.: Proof of Confusion Essential for Trademark Injunction - (Posted On Thursday, August 27, 2015) Applicability of the Entire Market Value Rule in Hatch-Waxman Cases - (Posted On Sunday, May 31, 2015) Lost Profits Are Hard to Come By: Warsaw Orthopedic v. NuVasive Patent Litigation - (Posted On Saturday, May 02, 2015) Pagination Page 1 Next page Next › Current Legal Analysis August 2025 ESG Policy Update—Australia by: Jim Bulling , Clive Cachia Avoiding Legal Pitfalls When Employees Are Arrested Off Duty by: Sarah W. Walsh Three Steps to Protect Your Insurance Program During National Preparedness Month by: Katherine J. Henry , Aaron J. Campbell Mintz IRA Update — 340B Roundup: CMS Proposes Steeper OPPS Clawbacks, Launches Drug Cost Survey with Public Comment by: Lauren M. Moldawer , Xavier G. Hardy AI Vendor Liability Squeeze: Courts Expand Accountability While Contracts Shift Risk by: Jason M. Loring , Lara Sevener HHS Announces Release of MAHA Strategy by: James V. Aidala , Lisa R. Burchi Don’t Fall Behind: The CMMC Final Rule to Update the DFARS is Here! by: Townsend L. Bourne Implications for ECI Risk in Debt Investments - IRS Private Letter Ruling 202536015 by: Pallav Raghuvanshi WashU Law’s Bold Bid to Become the Global Leader in Legal AI by: Eliya France Nasdaq Proposes to Allow Trading of Tokenized Securities by: Wai L Choy , Louis Rambo Five Takeaways from the FTC’s Decision to Abandon the Noncompete Rule by: Taylor Appling , Benjamin R. Dryden AI Chatbots in the Medical Field: Healthcare Hero or HIPAA Nightmare? by: Amy Hill Mintz IRA Update — Still Undefeated: Government Notches Three More Victories in Negotiation Program Lawsuits by: Theresa C. Carnegie , Mitchell J. Clough The Washington Supreme Court’s Decision in Branson v. Washington Fine Wine & Spirits LLC and Its Significance for Employers by: Robert T. Dumbacher , Meredith Gregston Mintz IRA Update — PhRMA’s 2025 Policy Agenda and the Industry’s Crossroads with the IRA and Drug Pricing Reform by: Theresa C. Carnegie , Ayaz R. Shaikh Upcoming Events Sep 18 2025 Workplace Horizons Extension: Chicago Sep 29-30 2025 Intellectual Property Law Institute 2025 - New York Oct 20-21 2025 Intellectual Property Law Institute 2025 - California Oct 21-22 2025 2025 Proxy Disclosure & 22nd Annual Executive Compensation Conferences Print
